Diphtheria-pertussis-tetanus vaccines | Tenderlake

Diphtheria-pertussis-tetanus vaccines

Contract Value:
EUR 10M - 10M
Notice Type:
Contract Notice
Published Date:
09 November 2022
Closing Date:
14 December 2022
Location(s):
ES21 País Vasco (ES Spain/ESPAÑA)
Description:
: "Acquisition of hexavalent combined vaccine against Diphtheria, Tetanus-Acellular Pertussis, Injectable Poliomyelitis, Haemophillus influenzae type b and Hepatitis B (DTa-IPV-Hbi_VHB), destined for

"Acquisition of hexavalent combined vaccine against Diphtheria, Tetanus-Acellular Pertussis, Injectable Poliomyelitis, Haemophillus influenzae type b and Hepatitis B (DTa-IPV-Hbi_VHB), destined for the vaccination program of the Basque Country, in the terms that appear in the specification of particular technical prescriptions."

"Acquisition of hexavalent combined vaccine against Diphtheria, Tetanus-Acellular Pertussis, Injectable Poliomyelitis, Haemophillus influenzae type b and Hepatitis B (DTa-IPV-Hbi_VHB), destined for the vaccination program of the Basque Country, in the terms that appear in the specification of particular technical prescriptions."

Download full details as .pdf
The Buyer:
Gobierno Vasco.
CPV Code(s):
33651610 - Diphtheria-pertussis-tetanus vaccines